Eloxx Pharmaceuticals, Inc. (ELOX) earnings
Quarterly and annual ELOX reports and results, each read against the price at its own news timestamp. Back to the ELOX overview →
13 measured ELOX earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | -0.04% | -7.85% | |
| Form 10-Q Eloxx Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -0.04% | -7.85% | |
| Form 10-Q Eloxx Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +2.86% | -25.71% | |
| Form 10-K Eloxx Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.00% | |
| Form NT 10-Q Eloxx Pharmaceuticals, For: Jun 30 | SEC filing · Form NT | — | — | |
| Form NT 10-Q Eloxx Pharmaceuticals, For: Mar 31 | SEC filing · Form NT | +0.00% | +0.00% | |
| Form NT 10-K Eloxx Pharmaceuticals, For: Dec 31 | SEC filing · Form NT | — | — | |
| Form NT 10-Q Eloxx Pharmaceuticals, For: Sep 30 | SEC filing · Form NT | — | — | |
| Form NT 10-Q Eloxx Pharmaceuticals, For: Jun 30 | SEC filing · Form NT | — | — | |
| Form NT 10-Q Eloxx Pharmaceuticals, For: Mar 31 | SEC filing · Form NT | +0.00% | +0.32% | |
| Form NT 10-K Eloxx Pharmaceuticals, For: Dec 31 | SEC filing · Form NT | +0.00% | +2.04% | |
| Eloxx Pharmaceuticals Reports Third Quarter 2023 Financial and Operating Results and Provides Business Update | Press release | +0.59% | -7.79% | |
| Form 10-Q Eloxx Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +0.59% | -7.79% |
Keep exploring
More ELOX: analyst actions → · SEC filings → · ELOX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| UCB SA UNSP/ADR (UCBJY) | 85 | +0.00% | 51% |
| NUO THERAPEUTICS INC NEW (AURX) | 84 | 0.00% | 24% |
| Knight Therapeutics Inc (GUD_TSE) | 84 | 0.00% | 40% |
| Molecular Templates, Inc. (MTEM) | 84 | -0.48% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.